Sad stuff, this Mitchell Report on drug use in Major League Baseball. In giving it a quick read, however, with my stock ticker hat on, about the only company that shows up in a negative way is Quest Diagnostics (NYSE:DGX), with some indirect suggestion in the report that a few MLB players got a heads-up on supposedly random drug testing conducted, in part, by Quest. It is an allegation, however indirect, that Quest denies.
Trading the Mitchell Report
By December 13, 2007 · ··